Literature DB >> 23019300

Semen apoptotic M540 body levels correlate with testis abnormalities: a study in a cohort of infertile subjects.

F Lotti1, L Tamburrino, S Marchiani, M Muratori, G Corona, M G Fino, S Degl'Innocenti, G Forti, M Maggi, E Baldi.   

Abstract

STUDY QUESTION: What are the associations between semen apoptotic M540 bodies and other parameters of semen quality and sonographic alterations of the male genital tract in a cohort of infertile subjects? SUMMARY ANSWER: In infertile subjects, semen M450 bodies are highly correlated with ultrasound and clinical signs of testis abnormalities but not with alterations of other parts of the male genital tract, suggesting a testicular origin of M540 bodies. WHAT IS KNOWN ALREADY: We have reported the presence in semen of round anucleate elements, named 'M540 bodies', resembling apoptotic bodies as they contain several apoptotic markers. STUDY DESIGN AND SIZE: A consecutive series of 130 males with couple infertility were evaluated, during the same day session, for clinical, scrotal and transrectal color-Doppler ultrasound characteristics, and hormonal and semen parameters, including interleukin 8 (sIL-8) and M540 body levels. PARTICIPANTS/MATERIALS, SETTING
METHODS: Semen parameters were analyzed by WHO recommended procedures. CDU was performed using the ultrasonographic console Hitachi H21. sIL-8 and serum hormones were evaluated by ELISA methods. MAIN RESULTS AND THE ROLE OF CHANCE: The average percentage value of M540 bodies was 24.6 ± 18.3. After adjusting for possible confounders (age, waist, calculated free testosterone and smoking habit), M450 body levels negatively correlated with sperm number/ejaculate, progressive motility, normal morphology and sIL-8 levels (adj.r = -0.455, P < 0.0001; adj.r = -0.464, P < 0.0001; adj.r = -0.430, P < 0.001; adj.r = -0.236, P < 0.05, respectively). In a subset of patients with a history of cryptorchidism (n = 8), M540 bodies were higher than in non-cryptorchid men (40.5 ± 14.8 versus 23.6 ± 18.2%; P < 0.02). A negative correlation was found between M540 and ultrasound testis volume (adj.r = -0.241, P < 0.05), whereas a positive association was found with testis inhomogeneity [HR = 1.06 (1.02-1.09); P = 0.002], hypoechogenicity [HR = 1.05 (1.01-1.08); P < 0.02] and FSH levels (adj.r = 0.309, P < 0.01). No relationships were found with CDU characteristic of the prostate, seminal vesicles, epididymis and vas deferens. In a multivariate model, testis inhomogeneity and history of cryptorchidism were independently associated with M540 body levels (adj.r = 0.355, P < 0.01 and adj.r = 0.223, P < 0.05, respectively). Receiver operating characteristic analysis demonstrated that at the threshold of 27%, M540 bodies discriminate subjects with testis inhomogeneity with a sensitivity of 72% and specificity of 73%. LIMITATIONS, REASONS FOR CAUTION: The increased M540 body semen levels in men with a history of cryptorchidism should be confirmed in a larger number of patients. WIDER IMPLICATIONS OF THE
FINDINGS: M540 bodies may be considered a semen marker of altered testis function and thus their evaluation may be helpful in the diagnosis of male infertility. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants from Ministry of University and Scientific Research (Prin project to E.B. and FIRB project to S.M.) and Regione Toscana (to G.F.).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019300     DOI: 10.1093/humrep/des348

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Multivariate analysis to predict letrozole efficacy in improving sperm count of non-obstructive azoospermic and cryptozoospermic patients: a pilot study.

Authors:  Giorgio Cavallini; Giulio Biagiotti; Elisa Bolzon
Journal:  Asian J Androl       Date:  2013-10-14       Impact factor: 3.285

2.  Investigation on the Origin of Sperm DNA Fragmentation: Role of Apoptosis, Immaturity and Oxidative Stress.

Authors:  Monica Muratori; Lara Tamburrino; Sara Marchiani; Marta Cambi; Biagio Olivito; Chiara Azzari; Gianni Forti; Elisabetta Baldi
Journal:  Mol Med       Date:  2015-01-30       Impact factor: 6.354

3.  Seminal plasma HSPA2 mRNA content is associated with semen quality.

Authors:  Yonghong Tian; Lejun Li; Fengbin Zhang; Jian Xu
Journal:  J Assist Reprod Genet       Date:  2016-05-21       Impact factor: 3.412

4.  Biochemical Assessments of Seminal Plasma Zinc, Testis-Expressed Sequence 101 and Free Amino Acids and Their Correlations with Reproductive Hormones in Male Infertility.

Authors:  Tahia H Saleem; Marwa Okasha; Hassan M Ibrahim; Mohammed Abu El-Hamd; Hanan M Fayed; Mohammed H Hassan
Journal:  Biol Trace Elem Res       Date:  2020-08-07       Impact factor: 3.738

5.  Subsequent impaired fertility (with or without sperm worsening) in men who had fathered children after a left varicocelectomy: A novel population?

Authors:  Giorgio Cavallini; Giovanni Beretta; Giulio Biagiotti; Roberto Mallus; Carlo Maretti; Edoardo Pescatori; Gianni Paulis
Journal:  Urol Ann       Date:  2015 Jan-Mar

6.  DNA fragmentation in two cytometric sperm populations: relationship with clinical and ultrasound characteristics of the male genital tract.

Authors:  Francesco Lotti; Lara Tamburrino; Sara Marchiani; Elisa Maseroli; Pasquale Vitale; Gianni Forti; Monica Muratori; Mario Maggi; Elisabetta Baldi
Journal:  Asian J Androl       Date:  2017 May-Jun       Impact factor: 3.285

7.  Vas deferens sonographic appearances of tuberculosis lesions of 19 cases of male genital systemic tuberculosis.

Authors:  Jigang Jing; Hua Zhuang; Yan Luo; Huijiao Chen; Yaping Rao
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

Review 8.  Tracking research trends and hotspots in sperm DNA fragmentation testing for the evaluation of male infertility: a scientometric analysis.

Authors:  Saradha Baskaran; Ashok Agarwal; Manesh Kumar Panner Selvam; Renata Finelli; Kathy Amy Robert; Concetta Iovine; Peter Natesan Pushparaj; Luna Samanta; Avi Harlev; Ralf Henkel
Journal:  Reprod Biol Endocrinol       Date:  2019-12-26       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.